UVA radiation induces suppression of perforin-granule release from CD8 hi+ cytotoxic T lymphocytes ex vivo [1]

Journal of Investigative Dermatology

Volumn 123, Issue 1, 2004, Pages 237-239

  Ambach, Andreas ^a   Bonnekoh, Bernd ^a   Gollnick, Harald ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; PERFORIN;

CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOREGULATION; INHIBITION KINETICS; LETTER; PRIORITY JOURNAL; PROTEIN SECRETION; RADIATION DOSE; TUMOR IMMUNITY; ULTRAVIOLET A RADIATION;

EID: 1842466554     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.22705.x     Document Type: Letter

References (15)

1. Ambach A, Bonnekoh B, Gollnick H: Perforin hyperreleasability and depletion in cytotoxic T cells of patients affected with exacerbated atopic dermatitis and asymptomatic rhinoconjunctivitis allergica. J Allergy Clin Immunol 107:878-886, 2001a
2. Ambach A, Bonnekoh B, Gollnick H: Perforin granule release from cytotoxic lymphocytes ex vivo is inhibited by ciclosporin, but not by methotrexate. Skin Pharmacol Appl Skin Phys 14:249-260, 2001b
3. Ambach A, Bonnekoh B, Gollnick H: Routine flow cytometric immuno-staining of T-cellular perforin is preserved using diethylene glycol for erythrocytelysis but lost by the use of ammonium chloride. Exp Dermatol 12:1-7, 2003
4. + blood lymphocytes in generalized non-anaphylactic drug eruptions and exacerbated psoriasis. Eur J Dermatol 10:1-5, 2000
5. Darmon AJ, Ley TJ, Nicholson DW, Bleackley RC: Cleavage of CPP32 by granzyme B represents a critical role for granzyme B in the induction of target cell DNA fragmentation. J Biol Chem 271:21709-21712, 1996
6. + T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur J Immunol 27:3341-3349, 1997
7. Kagi D, Ledermann B, Burki K, Hengartner H, Zinkernagel RM: CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur J Immunol 24:3068-3072, 1994
8. + T cells by perforin. Eur J Immunol 29:3262-3272, 1999
9. McGinley J, Martin CJ, MacKie RM: Sunbeds in current use in Scotland: A survey of their output and patterns of use. Br J Dermatol 139:428-438, 1998
10. Russell JH, Ley TJ: Lymphocyte mediated cytotoxicity. Annu Rev Immunol 20:323-370, 2002
11. Schulz M, Schuurman HJ, Joergensen J, et al: Acute rejection of vascular heart allografts by perforin-deficient mice. Eur J Immunol 25:474-480, 1995
12. Shustov A, Luzina I, Nguyen P, Papadimitriou JC, Handwerger B, Elkon KB, Via CS: Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity. J Clin Invest 106:R39-R47, 2000
13. Street SE, Cretney E, Smyth MJ: Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. Blood 97:192-197, 2001
14. Weren A, Bonnekoh B, Schraven B, Gollnick H, Ambach A: A novel flow cytometric assay focussing on perforin release mechanisms of cytotoxic T lymphocytes. J Immunol Methods, 2003, in press
15. + CTL directed against herpes simplex virus-infected cells. J Immunol 162:6100-6106, 1999